Brief Communication | Published:

Molecular targets for therapy

Constitutive activation of nuclear factor kappa B-inducing kinase counteracts apoptosis in cells with rearranged mixed lineage leukemia gene

Leukemiavolume 32pages24982501 (2018) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Winters AC, Bernt KM. MLL-rearranged leukemias—an update on science and clinical approaches. Front Pediatr. 2017;5:4.

  2. 2.

    Cornelissen JJ, Versluis J, Passweg JR, van Putten WL, Manz MG, Maertens J, et al. Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia. 2015;29:1041–50.

  3. 3.

    Kuo HP, Wang Z, Lee DF, Iwasaki M, Duque-Afonso J, Wong SH, et al. Epigenetic roles of MLL oncoproteins are dependent on NF-kappaB. Cancer Cell. 2013;24:423–37.

  4. 4.

    Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007;12:115–30.

  5. 5.

    Demchenko YN, Glebov OK, Zingone A, Keats JJ, Bergsagel PL, Kuehl WM. Classical and/or alternative NF-kappaB pathway activation in multiple myeloma. Blood. 2010;115:3541–52.

  6. 6.

    Saitoh Y, Yamamoto N, Dewan MZ, Sugimoto H, Martinez Bruyn VJ, Iwasaki Y, et al. Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells. Blood. 2008;111:5118–29.

  7. 7.

    Sun S-C. The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol. 2017;17:545.

  8. 8.

    Wei J, Wunderlich M, Fox C, Alvarez S, Cigudosa JC, Wilhelm JS, et al. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Cancer Cell. 2008;13:483–95.

  9. 9.

    Becker MW, Jordan CT. Leukemia stem cells in 2010: current understanding and future directions. Blood Rev. 2011;25:75–81.

  10. 10.

    Mulloy JC, Jankovic V, Wunderlich M, Delwel R, Cammenga J, Krejci O, et al. AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion. Proc Natl Acad Sci USA. 2005;102:4016–21.

  11. 11.

    Fernandes MT, Ghezzo MN, Silveira AB, Kalathur RK, Póvoa V, Ribeiro AR, et al. Lymphotoxin-β receptor in microenvironmental cells promotes the development of T-cell acute lymphoblastic leukaemia with cortical/mature immunophenotype. Br J Haematol. 2015;171:736–51.

  12. 12.

    Migliazza A, Lombardi L, Rocchi M, Trecca D, Chang CC, Antonacci R, et al. Heterogeneous chromosomal aberrations generate 3’ truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. Blood. 1994;84:3850–60.

  13. 13.

    Jin HR, Jin X, Lee JJ. Zinc-finger protein 91 plays a key role in LIGHT-induced activation of non-canonical NF-kappaB pathway. Biochem Biophys Res Commun. 2010;400:581–6.

  14. 14.

    Jin X, Jin HR, Jung HS, Lee SJ, Lee JH, Lee JJ. An atypical E3 ligase zinc finger protein 91 stabilizes and activates NF-kappaB-inducing kinase via Lys63-linked ubiquitination. J Biol Chem. 2010;285:30539–47.

  15. 15.

    Unoki M, Okutsu J, Nakamura Y. Identification of a novel human gene, ZFP91, involved in acute myelogenous leukemia. Int J Oncol. 2003;22:1217–23.

  16. 16.

    Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop. Nat Cell Biol. 1999;1:227–33.

Download references

Acknowledgements

The authors kindly thank Prof. J.C. Mulloy and Dr. M. Wunderlich for providing CD34+MLL-AF9 and CD34+AML1-ETO cells, respectively. This work was supported by grants from the German Federal Ministry of Education and Research (e:Bio, 031A304) and the Ministry of Economy, Research and Digitalization of Saxony-Anhalt (support from the European Fund for Regional Development (EFRD) (ZS/2016/04/78155)) to MN.

Author contributions:

MS-T and MN designed the study. MS-T and GM performed experiments. MS-T, MHF, and MN analyzed and interpreted the data. MS-T, MHF, GM, and MN wrote and revised the manuscript.

Author information

Affiliations

  1. Institute of Experimental Internal Medicine, Medical Faculty, Otto von Guericke University, Magdeburg, Germany

    • Maja Studencka-Turski
    • , Gunter Maubach
    • , Michael Hartmut Feige
    •  & Michael Naumann

Authors

  1. Search for Maja Studencka-Turski in:

  2. Search for Gunter Maubach in:

  3. Search for Michael Hartmut Feige in:

  4. Search for Michael Naumann in:

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding author

Correspondence to Michael Naumann.

Electronic supplementary material

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/s41375-018-0128-7